[Effect of DRB/alpha-Amanitin on localization of Nrf2 in A549 cells]

Li-yan Qu1, Yan-ling Jiang, Xiu-wen Tang

  • 1Department of Biochemistry and Genetics, College of Medicine, Zhejiang University, Hangzhou, China.

Abstract

Insights

Transcriptional inhibitors 5, 6-dichloro-1-b-D-ribofuranosylbenzimidazole (DRB) and alpha-Amanitin reduce Nrf2 and its target gene expression. These inhibitors do not significantly alter the nuclear localization of Nrf2.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Biochemistry

Background:

  • Nuclear factor erythroid 2-related factor 2 (Nrf2) is a key regulator of the antioxidant response.
  • Transcriptional inhibitors like DRB and alpha-Amanitin are used to study gene expression regulation.
  • Understanding Nrf2's nuclear localization is crucial for comprehending its role in cellular defense.

Purpose of the Study:

  • To investigate the impact of DRB and alpha-Amanitin on Nrf2 nuclear localization.
  • To analyze the effects of these inhibitors on the expression of Nrf2 and its downstream targets.

Main Methods:

  • A549 cells were treated with DRB or alpha-Amanitin.
  • Western blotting was employed to detect protein expression levels.
  • Laser scanning confocal microscopy was used to determine Nrf2 localization.

Main Results:

  • DRB and alpha-Amanitin treatment led to decreased expression of Nrf2 and its target genes (HO-1, NQO1, AKR1C).
  • SC35 expression was upregulated, while RNA Pol II expression was downregulated.
  • No significant changes were observed in the nuclear localization of Nrf2.

Conclusions:

  • DRB and alpha-Amanitin effectively downregulate Nrf2-mediated gene expression.
  • These transcriptional inhibitors do not appear to affect the nuclear localization of Nrf2.

Related Concept Videos